BCM
ACLX

Bayesian Capital Management’s Arcellx ACLX Stock Holding History

Bayesian Capital Management’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,100
Closed -$219K – 707
2023
Q3 		$219K Buy
+6,100
New +$210K 0.03% 537

Other funds holding ACLX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Bayesian Capital Management's ACLX Position: Q4 2023 in Review

Bayesian Capital Management sold out of Arcellx (ACLX) in Q4 2023, closing a stake of 6,100 shares — an estimated $219K sold.

Bayesian Capital Management first reported a position in ACLX in Q3 2023 and held it in 1 quarter. The position peaked at $219K in Q3 2023. 156 funds tracked by Wall St. Rank hold ACLX as of Q4 2023.

  • Bayesian Capital Management reported no remaining Arcellx position as of Q4 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 6,100 Arcellx shares in Q4 2023, an estimated $219K.
  • Bayesian Capital Management first reported a position in Arcellx in Q3 2023 and held it in 1 quarter.
  • Bayesian Capital Management's Arcellx position peaked at $219K in Q3 2023.
  • 156 funds tracked by Wall St. Rank held Arcellx as of Q4 2023.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.